医学
缺铁
铁蛋白
静脉注射铁
不利影响
麦芽糖
儿科
平均红细胞体积
内科学
外科
红细胞压积
贫血
生物化学
酶
化学
作者
K. R. Bharathi,Pooja Bhat
出处
期刊:International journal of reproduction, contraception, obstetrics and gynecology
[Medip Academy]
日期:2022-01-28
卷期号:11 (2): 405-405
标识
DOI:10.18203/2320-1770.ijrcog20220161
摘要
Background: Anaemia is a significant problem worldwide, particularly in women. Several intravenous iron preparations are available for the treatment of anaemia. Some of them cause life-threatening anaphylactic reactions while others require multiple small infusions to prevent iron reactions. Ferric carboxy maltose (FCM), a non-dextran intravenous iron, is safe and effective option that can be administered as single high dose without serious adverse effects.Methods: A prospective study was undertaken in the department of obstetrics and gynecology, Adichunchungiri institute of medical sciences, B G Nagara, from August 2020 to November 2021 in which 50 cases with iron deficiency anaemia were enrolled. IV FCM 1g was given. Change in the laboratory parameters such as haemoglobin (Hb), mean corpuscular value, serum ferritin levels over a 4 weeks period were observed.Results: A significant increase in mean Hb from 8.14 to 11.71 g was observed in patients treated with FCM after 4 weeks of therapy. Majority belonged to age group of 21-30 years and moderate type of anaemia was most common. No serious drug reaction was reported.Conclusions: IV FCM is safe and effective option for improving Hb in iron deficiency anaemia, in terms of restoring iron stores in short duration of time as well as patient compliance.
科研通智能强力驱动
Strongly Powered by AbleSci AI